Peer Review reports
From: MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer
Original Submission | ||
---|---|---|
11 Jun 2022 | Submitted | Original manuscript |
21 Aug 2022 | Reviewed | Reviewer Report - Jasvinder Singh |
26 Aug 2022 | Reviewed | Reviewer Report |
13 Sep 2022 | Author responded | Author comments - Wang Gongxian |
Resubmission - Version 2 | ||
13 Sep 2022 | Submitted | Manuscript version 2 |
22 Sep 2022 | Author responded | Author comments - Wang Gongxian |
Resubmission - Version 3 | ||
22 Sep 2022 | Submitted | Manuscript version 3 |
24 Sep 2022 | Author responded | Author comments - Wang Gongxian |
Resubmission - Version 4 | ||
24 Sep 2022 | Submitted | Manuscript version 4 |
25 Sep 2022 | Author responded | Author comments - Wang Gongxian |
Resubmission - Version 5 | ||
25 Sep 2022 | Submitted | Manuscript version 5 |
14 Oct 2022 | Reviewed | Reviewer Report |
24 Oct 2022 | Reviewed | Reviewer Report - Jasvinder Singh |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
31 Oct 2022 | Editorially accepted | |
11 Nov 2022 | Article published | 10.1186/s12885-022-10259-2 |
You can find further information about peer review here.